Related content

A Translational View of Peptide Treatment of Neurological Disorders

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2583-2590

Bentham Science Publishers

Access to resources Recommend Favorite

Davunetide: Peptide Therapeutic in Neurological Disorders

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2591-2598

Bentham Science Publishers

Access to resources Recommend Favorite

Immunophilin ligands for the treatment of neurological disorders

By Hamilton G.S.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1109-1124

Informa Healthcare

Access to resources Recommend Favorite

Stem Cells for the Treatment of Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 1, 2008-02 ,pp. : 98-109

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 166-194

Bentham Science Publishers

Access to resources Recommend Favorite